Who Paid My Doc Search
Menu
Product Program year 2020 Source: CMS Open Payments

Mk-7339

Drug Oncology

Open in the dashboard

General payments

$1,439,206

722 payments

Research payments

$20,475,263

5,055 payments

Through program year 2020, $1,439,206 in general payments and $20,475,263 in research payments were reported against Mk-7339 (Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $1,344,011 421
2020 Research $17,683,512 4,078
2019 General $95,195 301
2019 Research $2,791,751 977

Breakdown

Who paid General payments · program years 2019–2020
  1. Merck Sharp & Dohme Corporation $1,439,206 722 payments
Top recipients General payments · program year 2020
  1. Sergey Leshchinskiy Diagnostic Radiology · Burlington, VT $217,765 16% · 21 payments
  2. Petar Duvnjak Diagnostic Radiology · Milwaukee, WI $154,434 11% · 29 payments
  3. Rendon Nelson Diagnostic Radiology · Durham, NC $148,335 11% · 35 payments
  4. Ashraf Thabet Diagnostic Radiology · Boston, MA $102,805 8% · 14 payments
  5. Rajan Agarwal Diagnostic Radiology · Abington, PA $90,443 7% · 28 payments

The top 5 of 48 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Diagnostic Radiology Radiology $1,165,205 92% · 24 practitioners
  2. Vascular & Interventional Radiology Radiology $48,900 4% · 1 practitioner
  3. Medical Oncology Internal Medicine $15,178 1% · 8 practitioners
  4. Gynecologic Oncology Obstetrics & Gynecology $12,450 <1% · 6 practitioners
  5. Hematology & Oncology Internal Medicine $11,878 <1% · 5 practitioners

The top 5 of 8 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. North Carolina $274,018 20% · 3 recipients
  2. New Jersey $258,798 19% · 6 recipients
  3. Vermont $217,765 16% · 1 recipient
  4. Massachusetts $176,580 13% · 7 recipients
  5. Wisconsin $154,434 11% · 1 recipient

The top 5 of 17 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

Records

722 general · 5,055 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record